Glucocorticoid regulation of growth hormone (GH) secretagogue-induced growth responses and GH secretagogue receptor expression in the rat

Growth Hormone and IGF Research

Volumn 10, Issue 1, 2000, Pages 45-52

  Thomas, G B ^a   Bennett, P A ^a   Carmignac, D F ^a   Robinson, I C A F ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Adrenal; Dexamethasone; GH; Growth; Receptor; Secretagogue

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GROWTH HORMONE RELEASING FACTOR RECEPTOR; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE;

ADRENAL GLAND; ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GROWTH REGULATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

EID: 0034109729     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.1999.0138     Document Type: Article

References (43)

1. Bowers C. Y., Momany F., Reynolds G. A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 114:1984;1537-1545.
2. Smith R. G., Cheng K., Schoen W. R. A nonpeptidyl growth-hormone secretagogue. Science. 260:1993;1640-1643.
3. Gertz B. J., Barrett J. S., Eisenhandler R. Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. J Clin Endocrinol Metab. 77:1993;1393-1397.
4. Smith R. G., Van der Ploeg L. H. T., Howard A. D. Peptidomimetic regulation of growth hormone secretion. Endocr Rev. 18:1997;621-645.
5. Howard A. D., Feighner S. D., Cully D. F. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 273:1996;974-977.
6. Smith R. G., Pong S-S., Hickey G. J. Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Rec Prog Horm Res. 51:1996;261-285.
7. McKee K. K., Palyha O. C., Feighner S. D. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogues receptors. Mol Endocrinol. 11:1997;415-423.
8. Guan X-M., Yu H., Palyha O. C. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res. 48:1997;23-29.
9. Bennett P. A., Thomas G. B., Howard A. D. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology. 138:1997;4552-4557.
10. Dickson S. L., Leng G., Robinson I. C. A. F. Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. Neuroscience. 53:1993;303-306.
11. Dickson S. L., Doutrelant V. O., Leng G. GH-deficient dw/dw rats and lit/lit mice show increased Fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide-6. J Endocrinol. 146:1995;519-526.
12. Dickson S. L., Luckman S. M. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology. 138:1997;771-777.
13. McDowell R. S., Elias K. A., Stanley M. S. Growth hormone secretagogues: Characterization, efficacy, and minimal bioactive conformation. PNAS. 92:1995;11165-11169.
14. Jacks T., Hickey G., Judith F. Effects of acute and repeated intravenous administration of L-692,585, a novel-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles. J Endocrinol. 143:1994;399-406.
15. Bowers C. Y., Reynolds G. A., Durham D., Barrera C. M., Pezzoli S. S., Thorner M. O. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab. 70:1990;975-982.
16. Hickey G., Jacks T., Judith F. Efficacy and specificity of L-692,429, a novel nonpeptidyl growth-hormone secretagogue, in beagles. Endocrinology. 134:1994;695-701.
17. Hickey G. J., Drisko J., Faidley T. Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585. J Endocrinol. 148:1996;371-380.
18. Frieboes R. M., Murck H., Maier P., Schier T., Holsboer F., Steiger A. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology. 61:1995;584-589.
19. Copinschi G., Van Onderbergen A., L'Hermite-Baleriaux M. Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. J Clin Endocrinol Metab. 81:1996;2776-2782.
20. Thomas G. B., Fairhall K. M., Robinson I. C. A. F. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology. 138:1997;1585-1591.
21. Carmignac D. F., Bennett P. A., Robinson I. C. A. F. Effects of growth hormone secretagogues on prolactin release in anaesthetized dwarf (dw/dw) rats. Endocrinology. 139:1998;3590-3596.
22. Arvat E., Di Vito L., Maccagno B. Effects of GHRP-2 and hexarelin, two synthetic releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides. 18:1997;885-891.
23. Arvat E., Maccagno B., Ramunni J. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin in adrenocorticotropin and cortisol secretion in humans. Neuroendocrinology. 66:1997;432-438.
24. Giustina A., Wehrenberg W. B. The role of glucocorticoids in the regulation of growth hormone secretion: mechanisms and clinical significance. TEMS. 3:1992;306-311.
25. Ortoft G., Oxlund H., Jorgensen P. H., Andreassen T. T. Glucocorticoid treatment or food-deprivation counteract the stimulating effect of growth-hormone on rat cortical bone strength. Acta Paediatr. 81:1992;912-917.
26. Dieguez C., Mallo F., Senaris R. Role of glucocorticoids in the neuroregulation of growth hormone secretion. J Pediatr Endocrinol Metab. 9(Suppl.3):1996;255-260.
27. Clark R. G., Thomas G. B., Mortensen D. L. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker Diabetic Fatty rat. Endocrinology. 138:1997;4316-4323.
28. Thomas G. B., Bennett P. A., Carmignac D. F., Robinson I. C. A. F. Glucocorticoid regulation of GH-releasing peptide-6-induced growth responses and GH secretagogue-receptor gene expression in the rat. Proc Ann Mtg US Endocr Soc. 1998;P2-221.
29. Carmignac D. F., Robinson I. C. A. F., Enberg B., Norstedt G. Growth hormone receptor regulation in growth hormone-deficient dwarf rats. J Endocrinol. 138:1993;267-274.
30. Huhn W. C., Hartman M. L., Pezzoli S. S., Thorner M. O. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus. J Clin Endocrinol Metab. 76:1993;1202-1208.
31. Jaffe C. A., Ho P. J., Demott-Friberg R., Bowers C. Y., Barkan A. L. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. J Clin Endocrinol Metab. 77:1993;1641-1647.
32. Gabrielsson B. G., Carmignac D. F., Flavell D. M., Robinson I. C. A. F. Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat. Endocrinology. 136:1993;209-217.
33. Clark R. G., Robinson I. C. A. F. Up and down the growth hormone cascade. Cytokine and Growth Factor Revs. 7:1996;65-80.
34. Freedman M. R., Horwitz B. A., Stern J. S. Effect of adrenalectomy and glucocorticoid replacement on development of obesity. Am J Physiol. 250:1986;R595-R607.
35. Turkenkopf I. J., Kava R. A., Feldweg A. Zucker and Wistar diabetic fatty rats show different response to adrenalectomy. Am J Physiol. 261:1991;R912-R919.
36. Clark R. G., Carlsson L. M. S., Trojnar J., Robinson I. C. A. F. The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats. J Neuroendocrinol. 1:1989;249-255.
37. Voltz D. M., Piering A. W., Magestro M., Giustina A., Wehrenberg W. B. Effects of GHRP-6 and GHRH on GH secretion in rats following chronic glucocorticoid treatment. Life Sci. 56:1995;491-497.
38. Borges M-H. S., DiNinno F. B., Lengyel A-M. J. Different effects of growth hormone releasing peptide (GHRP-6) and GH-releasing hormone on GH release in endogenous and exogenous hypercortisolism. Clin Endocrinol. 46:1997;713-718.
39. Ghigo E., Arvat E., Ramunni J. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushings syndrome. J Clin Endocrinol Metab. 82:1997;2439-2444.
40. Rahim A., O'Neill P. A., Shalet S. M. The effect of chronic hexarelin administration on the pituitary-adrenal axis and prolactin. Clin Endocrinol (Oxf). 50:1999;77-84.
41. Svensson J., Lonn L., Jansson J. O., Murphy G., Wyss D., Krupa D., Cerchio K., Polvino W., Gertz B., Boseaus I., Sjostrom L., Bengtsson B. A. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab. 83:1998;362-369.
42. Pombo M., Barreiro J., Penalva A., Peino R., Dieguez C., Casanueva F. F. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone secretion (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection. J Clin Endocrinol Metab. 80:1995;3180-3184.
43. Popovic V., Damjanovic S., Micic D., Djurovic M., Dieguez C., Casanueva F. F. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamo-pituitary disconnection; evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab. 80:1995;942-947.